Pro Medicus Stock

Pro Medicus Equity

The The Equity of Pro Medicus (PME.AX) as of Sep 11, 2026 is 256.96 M AUD. In the previous year, The Equity was 187.73 M AUD — a change of 36.88% (higher).

Equity

256.96 MAUD

YoY

36.88%

Last updated:

In 2026, Pro Medicus's equity was 256.96 M AUD, a 36.88% increase from the 187.73 M AUD equity in the previous year.

The Pro Medicus Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
35.07 M AUD
Jan 1, 2019
49.29 M AUD
Jan 1, 2020
60.18 M AUD
Jan 1, 2021
81.68 M AUD
Jan 1, 2022
101.73 M AUD
Jan 1, 2023
138.78 M AUD
Jan 1, 2024
187.73 M AUD
Jan 1, 2025
256.96 M AUD
The Pro Medicus Equity history
YEAREquityYoY
256.96 MAUD+36.88%
187.73 MAUD+35.27%
138.78 MAUD+36.41%
101.73 MAUD+24.54%
81.68 MAUD+35.72%
60.18 MAUD+22.10%
49.29 MAUD+40.55%
35.07 MAUD+0.67%
34.83 MAUD+27.20%
27.39 MAUD+24.83%
21.94 MAUD+5.93%
20.71 MAUD—
Access this data via the Eulerpool API
Get Free API Key

Pro Medicus Stock analysis

What does Pro Medicus do? Pro Medicus Ltd. is an Australian company specializing in the development and distribution of medical imaging software solutions. The company was founded in 1983 and is headquartered in Melbourne. Pro Medicus is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Pro Medicus's Equity

Pro Medicus's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Pro Medicus's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Pro Medicus's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Pro Medicus's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Pro Medicus’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Pro Medicus stock

The Equity of Pro Medicus is 256.96 M AUD in 2026.

The Equity of Pro Medicus changed from 187.73 M AUD to 256.96 M AUD, representing a 36.88% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Pro Medicus since 2006 – with annual values, charts, and detailed analysis.

The Equity's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Pro Medicus historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Pro Medicus

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Pro Medicus